455 related articles for article (PubMed ID: 19222495)
21. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
22. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
24. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
25. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957
[TBL] [Abstract][Full Text] [Related]
26. Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study.
Ortiz S; Rodríguez JM; Soria T; Pérez-Flores D; Piñero A; Moreno J; Parrilla P
Otolaryngol Head Neck Surg; 2001 Mar; 124(3):261-5. PubMed ID: 11240987
[TBL] [Abstract][Full Text] [Related]
27. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
Kim WW; Ha TK; Bae SK
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of young adult thyroid papillary cancer patients with bilateral cervical metastases].
Zhang L; Guo Z; Wang YL; Ji QH
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):467-9. PubMed ID: 17686304
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
31. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
32. Clinical recurrence of papillary thyroid cancer in the remnant lobe.
Asanuma K; Kobayashi S; Sugenoya A; Yokoyama S; Shingu K; Hama Y; Itoh N; Kasuga Y; Amano J
Eur J Surg; 2000 Mar; 166(3):202-6. PubMed ID: 10755332
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
Sugitani I; Fujimoto Y; Yamamoto N
Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
[TBL] [Abstract][Full Text] [Related]
34. Importance of tumour size in papillary and follicular thyroid cancer.
Passler C; Scheuba C; Asari R; Kaczirek K; Kaserer K; Niederle B
Br J Surg; 2005 Feb; 92(2):184-9. PubMed ID: 15685703
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
36. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma.
Cipolla C; Sandonato L; Graceffa G; Fricano S; Torcivia A; Vieni S; Latteri S; Latteri MA
Am Surg; 2005 Oct; 71(10):874-8. PubMed ID: 16468540
[TBL] [Abstract][Full Text] [Related]
37. The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children.
Savio R; Gosnell J; Palazzo FF; Sywak M; Agarwal G; Cowell C; Shun A; Robinson B; Delbridge LW
J Pediatr Surg; 2005 Nov; 40(11):1696-700. PubMed ID: 16291154
[TBL] [Abstract][Full Text] [Related]
38. The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.
Giles Senyurek Y; Tunca F; Boztepe H; Alagöl F; Terzioglu T; Tezelman S
Surgery; 2009 Dec; 146(6):1188-95. PubMed ID: 19958948
[TBL] [Abstract][Full Text] [Related]
39. The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma.
Jara SM; Carson KA; Pai SI; Agrawal N; Richmon JD; Prescott JD; Dackiw A; Zeiger MA; Bishop JA; Tufano RP
Surgery; 2013 Dec; 154(6):1272-80; discussion 1280-2. PubMed ID: 24238047
[TBL] [Abstract][Full Text] [Related]
40. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer.
Zhang Y; Ma XP; Deng FS; Liu ZR; Wei HQ; Wang XH; Chen H
World J Surg Oncol; 2014 Sep; 12():277. PubMed ID: 25179111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
